Harbour BioMed and Bristol Myers Squibb (BMS) have signed a multi-year, worldwide strategic partnership and licence agreement ...
The US Centers for Disease and Prevention (CDC) no longer recommends that all US newborns receive the hepatitis B vaccine, ...
Targeted patient recruitment can increase the likelihood of trial success and help cultivate use of precision medicine.
INCOG BioPharma Services has announced an injectable drug manufacturing expansion at its Fishers facility in Indiana, US.
Cellular Origins is a UK‑based company enabling scalable, factory‑led automation for cell and gene therapy manufacturing, and ...
GSK's Exdensur (depemokimab) is now the first FDA-approved, twice-yearly add-on maintenance therapy for severe eosinophilic asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback